Table 1. Summary of Selected Articles

	Author (Year)	Sample size (EG/CG)	Intervention	Outcome measurement	Result
Mx	Yu (2014)	68(38/30)	EG: MxCG: Triamcinolone acetonide cream)	1st: ER2nd: Bl viscosity3rd: Bl test(IL-2,6,10, TNF-α)	1st: ER(76.3%, EG〉CG)2nd: Bl viscosity(EG〈CG)3rd: IL-2(EG〈CG)
Ac	Chu (2023)	8	EG: Needling + NB-UVBCG: NB-UVB	1st: VASI2nd: VAS of pain	1st: EG: 78.46±12.54 CG: 91.92±6.672nd: VAS AVE 3.54±1.2
	Zhang (2013)	93(48/45)	EG: FNCG: NB-UVB	ER	EG(79.2%) > CG(48.9%)
	Mohaghegh (2012)	21	EG: Needling + NB-UVBCG: NB-UVB	GR(G0-G3)	GR, G3 Repigmentation: EG(41.5%) > CG(14.6%)
	Zheng (2005)	116(58/58)	EG: Embedding needle + Stamp needleCG: Corticosteroid cream, Sicorten	ER	EG(98.3%) > CG(74.1%)

Mx: moxibustion, Ac: acupuncture, EG: experimental group, CG: control group, ER: effective rate, Bl: blood, IL: interleukin TNF-α: tumor necrosis factor-α, VASI: Vitiligo Area Scoring Index, VAS: Visual Analogue Scale, GR: grade of repigmentation, FN: fire needle